Stifel Financial Corp Heska Corp Transaction History

Stifel Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$62.17 - $97.62 $50,295 - $78,974	809 Added 16.61%	5,680 $554,000
Q4 2022 Feb 13, 2023	BUY	$60.21 - $77.74 $53,767 - $69,421	893 Added 22.45%	4,871 $302,000
Q3 2022 Nov 14, 2022	BUY	$72.92 - $99.73 $290,075 - $396,725	3,978 New	3,978 $290,000
Q2 2022 Aug 15, 2022	SELL	$84.23 - $147.57 $136,284 - $238,768	-1,618 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$122.89 - $171.74 $29,124 - $40,702	237 Added 17.16%	1,618 $224,000
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $46,488 - $79,202	298 Added 27.52%	1,381 $252,000
Q3 2021 Nov 15, 2021	SELL	$228.69 - $274.2 $25,155 - $30,162	-110 Reduced 9.22%	1,083 $280,000
Q2 2021 Aug 13, 2021	BUY	$169.89 - $231.37 $202,678 - $276,024	1,193 New	1,193 $274,000

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.